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Abstract
Thousands of long intergenic non-coding RNAs (lincRNAs) are encoded by the mammalian genome. However, the function
of most of these lincRNAs has not been identified in vivo. Here, we demonstrate a role for a novel lincRNA, linc-MYH, in adult
fast-type myofiber specialization. Fast myosin heavy chain (MYH) genes and linc-MYH share a common enhancer, located in
the fast MYH gene locus and regulated by Six1 homeoproteins. linc-MYH in nuclei of fast-type myofibers prevents slow-type
and enhances fast-type gene expression. Functional fast-sarcomeric unit formation is achieved by the coordinate expression
of fast MYHs and linc-MYH, under the control of a common Six-bound enhancer.
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Introduction
Adult skeletal muscles are composed of slow and fast myofiber
subtypes which selectively express the genes required for their
specific contraction activity and metabolic properties [1–4]. These
properties are acquired at the end of fetal development and during
the neonatal period, when mixed skeletal myofibers expressing a
panel of embryonic, fast and slow genes develop a specific slow or
fast phenotype. The formation of efficient fast sarcomeric units,
and Ca++ cycling and excitation/contraction/relaxation coupling
in fast-myofibers, is achieved through the coordinate control of fast
Myhs and associated fast sarcomeric genes (including Tnnt3, Tnni2,
Tnnc2, Atp2a1 and Pvalb) [2,4]. Myofibers can be classified by their
MYH expression profile: slow-type myofibers in mice express
MYH7 (also known as MYHCI, b or slow), and fast-myofibers
express MYH2 (MYHCIIA), MYH1 (MYHCIIX) or MYH4
(MYHCIIB). Fast Myh genes found in developmental and adult
stages (Myh3, Myh2, Myh1, Myh4, Myh8 and Myh13) are organized
as a cluster within a 300 kb region on mouse chromosome 11 [5].
The spatio-temporal expression of one specific fastMyh gene at the
Myh locus is reminiscent of the organization and expression of
Globin genes at the beta-globin locus [6]. However, we are yet to
investigate potential enhancers or the Myh locus control region
(LCR) that could be responsible for sequential and specific Myh
gene expression in myofibers. The coordination of fast-type and
slow-type gene expression in fast myofibers is not currently
understood. Distinct intramyofibrillary calcium transients, evoked
by slow tonic motor neuron firing, induce a cascade of
downstream signaling involving Calcineurin and CamK. This
results in the activation of selective transcription activators and
repressors in slow myofibres. However, the signaling pathways
operating in distinct Myh2, Myh1 and Myh4 myofiber subtypes,
which coordinate the activation of the other fast-type genes and
the repression of slow-type genes, is less well understood [1]. Better
knowledge of the mechanisms controlling muscle specialization
and plasticity is important to enable the understanding and
modulation of muscle adaptations in pathophysiological condi-
tions.
Six homeoproteins are major myogenic transcription factors
which directly bind to DNA sequences (called MEF3s) to control
myogenesis [7,8] and the genesis of fast-type myofibers during
embryogenesis [9,10]. In adult skeletal muscle, Six1 accumulates
at a higher level in the nuclei of adult fast myofibers than in of slow
myofibers. Forced expression of Six1 and its Eya1 cofactor in slow
myofibers causes adult slow-twitch oxidative fibers toward a fast-
twitch glycolytic phenotype [11]. Animals with a Six1 KO present
severe muscle hypoplasia and die at birth [12]. This prevents the in
vivo analysis of the adult phenotype and the ability to investigate
the direct or indirect involvement of Six1 in the spatio-temporal
control of the expression of genes in the fast Myh cluster.
The mammalian genome encodes thousands of long intergenic
non-coding RNAs (lincRNAs) which have multiple functions
[13,14]. Some accumulate in the cytoplam as miRNAs decoys
[15,16]. Others accumulate in the nucleus and participate to gene
regulation through chromatin remodeling and epigenetic modifi-
cations [14,17,18]. Here, they may act as cis [19] or trans [20]
transcriptional activators, as transcriptional repressors [21,22] or
through DNA-RNA triplex formation [23,24].
In this study we identify a new lincRNA, linc-MYH, and the
mechanism of its control of adult muscle fast fiber-type specification
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in vivo. We demonstrate a three-element genetic partnership,
where an enhancer element under the control of the myogenic
homeoprotein Six1 functions as a regulatory hub to control fiber
phenotype. In this partnership, the enhancer positively controls
the expression of both the adjacent fast Myh gene cluster and
linc-MYH, suppressing slow-type gene expression and facilitating
fast fiber-type specialization.
Results
Six1 binds directly to a newly identified enhancer of the
Myh genes cluster
Our previous studies suggested that Six1 could be directly
involved in the control of the expression of fast Myh genes, since
higher levels of this transcription factor accumulate in the nuclei of
adult fast myofibers than in slow myofibers [11]. To investigate
how Six1 could control the expression of fast Myh isoforms, we
used computational analysis to locate MEF3 sites at the fast Myh
locus (see Materials and Methods). Six clustered MEF3 sites are
conserved across human, rat and mouse genomes in an intergenic
region located 50 kb upstream of the Myh2 gene (Figures 1A and
S1) and 4 kb upstream of a lincRNA (2310065F04Rik); we refer to
this lincRNA as linc-MYH (Figures 1A and S2). Six1 binding at
these MEF3 sites was demonstrated in vivo by ChIP (Chromatin
Immunoprecipitation) experiments with Six1 antibodies on adult
fast gastrocnemius plantaris (GP) and tibialis anterior (TA) muscles
(Figure 1B) but not on adult slow Soleus (data not shown), and
confirmed for five of these sites (sites 1, 2, 3, 4 and 6) by EMSA
assays (Figure S3A). We asked whether this Myh intergenic region
could constitute an enhancer element, controlling the spatio-
temporal expression of Myh genes in this locus. A 2 kb DNA
fragment of this region, including the six identified MEF3 sites and
1 kb of DNA fragments upstream of the transcription start site of
fast-type Myh2, Myh1 and Myh4 genes, was isolated. The putative
enhancer was ligated to each Myh promoter using luciferase pGL3
basic plasmids to generate pGL3-Enhancer-Myh2/1/4 constructs.
To test the involvement of Six binding in enhancer activation of
the Myh2, Myh1 and Myh4 promoters, we mutated all six MEF3
sites present in the enhancer, and named these reporters pGL3-
mutEnhancer-Myh2/1/4. Luciferase activity was tested two weeks
after the electroporation of reporter plasmids in adult TA muscles.
The luciferase activity of pGL3-Enhancer-Myh2/1/4 was seven to
twelve times higher for either of the promoters, than with pGL3-
Myh2/1/4. Enhancer activity was not observed in plasmids with
mutated MEF3 sites associated with either of the Myh promoters
(Figure 1C). Enhancer activity was neither observed with the
promoters of the slow Sln (Figure S3B) or Tnni1 genes, or with the
promoter of the ubiquitous b-actin gene (Figure S3C). A weak
enhancer activity was observed with Myh4 promoter in primary
embryonic fibroblasts, in which Six1 is expressed (Figure S3D and
data not shown). These data showed that high MYH enhancer
activity was only reached in vivo and required specific interactions
with MYH promoter elements. To determine in vivo interactions
between the enhancer and each Myh gene, we performed
chromatin conformation capture (3C) assays of adult fast EDL
(Extensor digitorum longus) myofibers. These experiments re-
vealed that the enhancer interacts with the promoter of Myh2/1/4
genes in native chromatin of EDL myonuclei (Figure 1D). The
strongest interactions were observed with the Myh1 and Myh4
promoters, consistent with the expression profile of these two genes
in EDL muscles. The data demonstrates that the identified
conserved cis-element acts as an enhancer for the Myh locus and
that MEF3 sites are essential for its enhancer activity in vivo.
Loss of Six1 impairs fast muscle genes and linc-MYH
expression during post-natal development
To further characterize the role of Six1 in the control of fastMyh
gene expression, we bred Six1flox/flox mice with transgenic mice
expressing CRE recombinase under the control of the human
skeletal actin (HSA) promoter and obtained Six1flox/flox;HSA-CRE
conditional knockout mice (hereafter named cSix1 KO) [25,26]. We
analyzed the expression of fiber type specific genes in the back
muscles of wild-type control mice and cSix1 KO mice at embryonic
day 18.5 (E18.5) and at several post-natal stages (two weeks (P2W),
four weeks (P4W) and eight weeks (P8W)) animals (Figure 2), as
muscle fiber fast-subtype specialization takes place from the end of
embryogenesis [9]. Six1 mRNA was not detectable in back muscles
of cSix1 KO mice (Figure 2). The expression of fast-type genes
(Myh4, Tnnt3, Tnni2, Tnnc2 and Pvalb) increased during postnatal
development in control mice but that of slow-type genes (Myh7,
Tnnt1, Tnni1, Tnnc1 and Sln) decreased. The linc-MYH RNA was
detected after birth in muscle samples and its expression increased
in line with that of Myh4 (Figure 2). The induction of fast-type
genes and linc-MYH and the suppression of slow-type genes, were
impaired in cSix1 KOmice. Expression of linc-MYH was reduced by
three to five times in cSix1 KO mice during postnatal development
(Figure 2). These results show that Six1 controls the induction of
linc-MYH and fast-type genes during postnatal development, and is
required for the downregulation of slow type genes.
Six1 deficiency impairs adult muscle fast phenotype
We next analyzed adult 12 week-old cSix1 KO mice to further
characterize the role of Six1 in adult muscle. Six1 mRNA and
protein were not detectable in GP enriched with fast-myofibers or
soleus (SOL) muscle enriched with slow-myofibers (Figure 3A and
B), and fatigue resistance of TA muscle was 35% higher
(Figure 3C) in the cSix1 KO mice. We used immunohistochemistry
to analyse the composition of MYH7, MYH2 and MYH4 in cSix1
mutant myofibers. Mutant TA muscles had a higher percentage of
fibers containing MYH7 and MYH2, but a lower percentage of
fibers containing MYH4 (Figures 3D and S4). We found consistent
results during qPCR analysis of Myh mRNA i.e., higher levels of
Myh7 and Myh2 mRNA and lower levels of Myh4 mRNA levels
were observed in the fast TA muscles of cSix1 KO (Figure 3E).
Expression levels of other specific fast and slow-type genes were
also tested. We found in mutant TA muscles a downregulation of
fast-type genes (Tnnt3, Tnni2, Tnnc2 and Pvalb) and a five and to 25
fold increase in the levels of slow-type genes (Myh7, Tnnt1, Tnni1,
Author Summary
Adult skeletal muscles are classified into fast-type and
slow-type, which display different resistance to muscle
atrophy and metabolic protection against obesity. We
identify in this manuscript a new mechanism controlling in
vivo adult muscle fiber-type specification implicating a
long intergenic non-coding RNA, linc-MYH. We demon-
strate a three-element genetic partnership, where an
enhancer under the control of the myogenic homeopro-
tein Six1 functions as a regulatory hub to control fibre
phenotype. In this partnership, the enhancer controls
positively the expression of both the adjacent fast myosin
heavy chain (MYH) gene cluster and of linc-MYH. linc-MYH
is present only in adult fast type skeletal myofibers and
controls their phenotype by suppressing slow-type gene
expression. The regulation of linc-MYH could provide a
lead for new therapeutic approaches or drug develop-
ment.
linc-MYH Locks Fast Muscle Phenotype
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Tnnc1 and Sln) (Figure 3E). Nevertheless expression of slow Myh7 is
increased more than ten fold at the mRNA level in cSix1 mutant
TA myofibers, while by immunohistochemistry the number of
MYH7 positive myofibers is increased less than two fold. This
showed that there is no major phenotype switch in cSix1 mutant
TA myofibers. This observation could be explained either by the
higher amount of Myh7 mRNA accumulating in MYH7 positive
fibers or by a general increase of Myh7 mRNA in TA myofibers,
mRNAs that would not be translated efficiently and leading to the
absence of increase of MYH7 positive fibers. The expression of
linc-MYH expression was lower in the adult TA of cSix1 KO mice,
than in control mice (Figure 3E). These results indicate that the
Six1 homeoprotein can control the phenotype of fast skeletal
myofibers in adult animals.
linc-MYH is expressed exclusively in adult fast-type
muscles
We found that linc-MYH is expressed in fast-type skeletal
muscles (GP, TA and EDL), but not in SOL, brain, kidney, heart
or fat tissues, an expression pattern which parallels that of the fast-
fiber Myh4 (Figure 4A). This suggested that linc-MYH is only
expressed following robust nuclear accumulation of Six1, as takes
place in the nuclei of MYH4 myofibers [11], and that the weaker
nuclear accumulation of Six1 observed in SOL myonuclei does
not allow efficient Six1 binding on the MYH enhancer and linc-
MYH expression. We used luciferase reporter transfection assays
(as described above) to test the requirement for Six binding on the
MYH enhancer to activate linc-MYH expression. These transient
transfection assays, performed in adult TA, show that the MYH
enhancer activates linc-MYH expression in a Six-dependent
manner, as measured two weeks after electroporation (Figure 4B).
lincRNAs can localize in cytoplasm [16] or as a single focus [19] or
multiple foci [20] in nuclei. To analyze linc-MYH localization in
skeletal muscle fiber, we performed fluorescent in situ hybridization
(FISH), using linc-MYH sense and antisense RNA on isolated
myofibers from fast EDL. Intranuclear localization of linc-MYH
was observed with the antisense linc-MYH RNA probe, with
approximately 10 linc-MYH foci per nucleus (n = 10, Figure 4C),
while the sense linc-MYH RNA probe gave no signal (data not
shown). We concluded from these experiments that linc-Myh RNA
accumulates at specific sites in the nucleus of fast myofibers.
linc-MYH coordinates fiber-type gene expression
Due to the number of linc-MYH foci observed in fast type nuclei,
we hypothesized that linc-MYH could act in trans [17] to control
gene expression in fast myofibers. To test this theory, we used
electroporation to introduce a shRNA against linc-MYH (shlinc-
MYH) in TA muscle and analyzed the transfected samples after
fourteen days. This method yielded the efficient knockdown of linc-
MYH, with a 90% reduction of its expression (Figure 5A). To
identify the consequences of linc-MYH knockdown and understand
its mode of action, RNA samples from shlinc-MYH transfected
Figure 1. Six1 binds directly the enhancer of the fast Myh gene cluster. (A) Schematic representation of the fast Myh gene cluster. (B) qPCR
values of ChIP experiments performed with Six1 antibodies, or IgG on GP and TA chromatin, showing Six1 binding to P1 and P2 regions of the fast
Myh enhancer, to the muscle promoter of AldoA, and to an intergenic region located 86 kb 59 upstream of Myh3 (NC) (n = 3). (C) Luciferase assays
from adult TA muscles electroporated with luciferase vectors (indicated) and a TK-Rennila luciferase vector allowing normalization (n = 4). (D) qPCR
experiments from 3C assays of wild type EDL muscle, showing the direct interactions of Myh2, Myh1 and Myh4 promoters with the fast Myh enhancer.
*P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pgen.1004386.g001
linc-MYH Locks Fast Muscle Phenotype
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adult TA were analyzed by Affymetrix microarrays (Figure 5D
and Table S1), and validated by qPCR experiments (Figure 5A).
The expression of linc-MYH was significantly lower in the absence
of Six1, but Six1 expression was not affected by the absence of linc-
MYH. Knockdown of linc-MYH led to robust gene expression
modification; this knockdown strongly upregulated the expression
of numerous slow genes (such as Sln, Tnni1, Tnnc1 and Tnnt1) and
moderately downregulated the expression of several fast genes,
(including Myh4, Tnnt3, Tnni2 and Pvalb) (Figure 5A). We noted
that the expression of Sln and other slow genes remained far lower
in linc-MYH knockdown TA than in wild type Soleus. This showed
that linc-MYH knock down in TA is not sufficient to achieve the
full transcription efficiency of these slow genes as is observed in
SOL, where calcineurin and several kinases are required to
achieve their efficient transcription [27]. In addition, and contrary
to what was observed previously in the muscles of cSix1 KO mice,
slow Myh7 expression level did not change in linc-MYH knock
down TA. We next tested whether the transcription rate of Sln and
Tnnt1 slow genes was modified in linc-MYH knock down TA by
measuring their pre-mRNA expression level. As can be seen in
Figure 5B we observed an upregulation of pre-mRNA of these
slow genes after linc-MYH knock down, which is proportional to
their respective mRNA accumulation, demonstrating that their
transcription is increased after linc-MYH knock down in TA, and
showing that linc-Myh can act in trans to decrease their
transcription. Since we also observed a moderate down-regulation
of the expression of fast genes in linc-MYH knock down TA, among
which Myh4, we next tested whether the activity of the pGL3-
Enhancer-Myh4 reporter could be modulated by the absence of
linc-MYH. Two weeks after cotransfection of pGL3-Enhancer-
Myh4 and shlinc-MYH in TA, we observed a statistically significant
decrease of Luciferase activity, demonstrating the requirement of
linc-MYH for efficient transcription of MYH4 (Figure 5C). Alto-
gether these experiments show that accumulation of linc-Myh in the
nuclei of fast myofibers participates in the transcriptional silencing
of slow genes and is required for the full activation of fast genes.
Transcriptomic analysis of cSix1 and linc-MYH
We compared the networks of genes under the control of linc-
MYH and of Six1 homeoprotein in adult muscles by the
transcriptomic analysis of cSix1 and linc-MYH knockdown
(Figure 5D and Table S2). We found that the six genes whose
expression was the most increased in the linc-MYH knockdown
were also significantly upregulated in cSix1 KO muscles (Figure S5).
Figure 2. The expression of fast-type genes and linc-MYH is impaired in cSix1 KO mice during postnatal development. mRNA
expression level of Six1, linc-MYH, Myh3, slow-type genes (red) and fast-type genes (blue) in back muscles of cSix1 KO mice at E18.5, P2W, P4W and
P8W, as determined by qPCR experiments, (n = 3 to 6 for each point). *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pgen.1004386.g002
linc-MYH Locks Fast Muscle Phenotype
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Besides slow muscle genes, two genes, Ankrd1 and Peg10, were
more severely upregulated in the linc-MYH knockdown line (10
and 8 times, respectively) than in cSIX1 mutant myofibers (by 2.8
and 1.5 times, respectively). These non slow-type genes could be
exclusively repressed by linc-MYH in adult fast myofibers since
there is a stronger downregulation of linc-MYH accumulation after
its knockdown than in cSix1 mutant myofibers. Transcriptomic
analysis of adult myofibers deprived of either Six1 or of linc-Myh
identified a strong qualitative and quantitative correlation in the
expression of specific genes between linc-MYH knockdown and
cSix1 adult mutant myofibers. The expression of slow muscle genes
was 3 to 10 fold higher in linc-MYH knockdown samples, and 5 to
25 fold higher in cSix1KO samples, than in the wild type. We
further showed that linc-MYH lies downstream of Six1 in the Six
myogenic pathway and helps to repress slow muscle genes in fast
myofibers. The downregulation of all fast-type genes (other than
Myh4), and the upregulation of slow-type genes, was weaker in the
linc-MYH knockdown than in the Six1cKO line. Six1 may control
several inhibitory pathways, including the linc-MYH pathway, to
prevent slow-type genes expression in adult fast myofibers. During
fetal development, at a stage where linc-MYH expression is not yet
activated, Six1/4 increases the nuclear accumulation of the slow
muscle repressors Sox6 and HDAC4 to repress slow muscle gene
expression [9,28,29]. In accordance with this, the expression of the
slow genes Myh7, Sln, Tnni1 and Tnnt1 is upregulated in the
muscle-specific cSox6 mutant [30]. This demonstrates that linc-
MYH and Sox6, lying both downstream of Six1, directly
participate in the downregulation of Sln, Tnni1 and Tnnt1 in fast
myofibers. However, the repression of slow Myh7 in fast myofibers
acts by a Six1-Sox6 dependent, but linc-MYH independent,
repression mechanism. In this study, we observed that the levels
of fast muscle gene expression decreased by 2–3 folds in the linc-
MYH knockdown, with the highest decrease found for Myh4
expression. The expression of these genes decreased by a factor of
1.3 to 2.5 in cSix1KO, with the highest decrease found for Pvalb
expression (Figures 3E and 5A). The presence of Six4 and Six5
proteins in adult myofibers [11], which have the same DNA
binding specificity as Six1, could compensate its absence in cSix1
KO animals and enable the activation of downstream fast muscle
targets. In this case, linc-MYH expression could be preferentially
dependent upon Six1, rather than on Six4 or Six5. Altogether,
these experiments suggest that the accumulation of linc-MYH
transcripts in the nuclei of fast myofibers facilitates the regulation
of a network of genes that drive myofiber specialization via the
same pathway as Six1 and downstream of this transcription factor.
Forced expression of linc-MYH in adult slow Soleus
To test the possibility that linc-MYH could modulate the
expression of specific muscle genes, we forced its expression in
myogenic C2 cells and in primary myoblasts, where endogenous
Figure 3. Six1 deficiency impairs the adult phenotype of fast muscle. (A) Six1 mRNA expression levels in GP and Sol muscles of three month-
old control (Ctrl, n = 4) and cSix1 KO (n = 3) mice. (B) Western blot analysis of Six1 and btubulin expression in Sol and GP of Ctrl and cSix1 KO mice. (C)
Time to fatigue ratio of TA muscles of Ctrl (n = 4) and cSix1 KO (n = 4) mice. (D) Percentage of myofibers expressing MYH7, MYH2 and MYH4 in TA
muscles of three month-old Ctrl (n = 4) and cSix1 KO (n = 4) mice. (E) mRNA expression levels of slow-type genes (red), fast-type genes (blue) and linc-
MYH in TA muscles of three month-old Ctrl (n = 4) and cSix1 KO (n = 4) mice. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pgen.1004386.g003
linc-MYH Locks Fast Muscle Phenotype
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linc-MYH expression was faintly detectable even in myotubes four
days after their differentiation (data not shown). Transfection of a
13 kb genomic fragment encompassing the whole linc-MYH gene
lead to efficient linc-MYH RNA accumulation in myotubes, but
after this forced expression, we were unable to detect any
modification in the expression of slow or fast type genes (data
not shown). These results suggest that specific cofactors of linc-
MYH required for its appropriate functioning are lacking in
cultured myotubes in culture, in agreement with the expression of
linc-Myh only in adult fast type fibers. To circumvent the
limitations of cultured cells, we turned to in vivo experiments in
the Soleus in which linc-Myh is weakly expressed. Two weeks after
linc-MYH gene transfection in the Soleus we observed that linc-
MYH RNA accumulates up to approximately 80% of its
expression level in TA (Figure 5E). We observed a selective
upregulation of Myh4 and Pvalb mRNAs which were increased to
approximately one-third their expression level observed in TA,
while mRNA for slow genes remained unchanged (Figure 5E). To
test whether the increase in Myh4 and Pvalb mRNA was due to an
increased transcription of their genes, and potentially exclude a
mechanism implicating mRNA stabilization, we measured pre-
mRNA accumulation. As can be seen in Figure 5F, the
transcription of these two fast genes is upregulated in the Soleus
samples expressing linc-MYH proportionally to their mRNA
accumulation, demonstrating that linc-Myh can work in trans
and allow efficient activation of the transcription of specific fast
genes. Absence of down regulation of the expression of slow genes
in Soleus myofibers expressing linc-Myh suggests that, like in
cultured myotubes, linc-Myh RNA needs specific protein-binding
partners to achieve its function. Such specific protein-binding
partners may be absent in Soleus as well as in cultured myotubes.
Nuclear long non coding RNA are known to guide chromatin
modifiers to specific gene loci, and by recruiting histone modifiers
or DNA methyltransferase to modulate their transcription rate
[31]. Potential linc-Myh protein partners expressed differentially in
fast and slow adult myofibers may explain how linc-Myh efficiently
represses the transcription of slow genes and activates the
transcription of fast genes in fast myofibers, while in slow
myofibers its forced expression is only able to activate the
transcription of fast genes.
Discussion
The commitment and maintenance of muscle fiber fast sub type
specialization relies on the specific expression of one of the fast
Myosin heavy chain gene present at the fast Myh locus, and of
specific isoforms of sarcomeric genes [1,2,4]. Myosin heavy chains
are the primary determinant of the efficiency of muscle
contraction. In this manuscript, we identified a novel mechanism
for the specialization of the fast-myofiber subtype. We show that
the long intergenic non-coding RNA linc-MYH and fast MYH
genes, both of which are essential for myofiber specification, share
a common enhancer which is regulated by Six1 homeoproteins.
The linc-MYH specifically accumulates in nuclei of adult fast
myofibers. Its function, as revealed here by in vivo knockdown and
transcriptome-wide analysis, is to prevent slow-type muscle gene
transcription and increase fast-type muscle gene expression in
fast-type myofibers. We found linc-MYH downregulates the
transcription of genes associated with slow muscle contractile
properties like the slow genes Tnn and Sln (a known repressor of
Serca1/Atp2a1 protein [32,33] involved in Ca++ reuptake by the
sarcoplasmic reticulum). These genes, which belong to the muscle
contractile machinery and are repressed in adult fast myofiber, are
positively controlled by Six1 in myogenic C2 cells [34], where linc-
Figure 4. linc-MYH is expressed in adult fast-type skeletal muscles and accumulates in their nuclei. (A) Tissue distribution of Six1, Myh4
and linc-MYH RNAs. BAT, brown adipose tissue; WAT, white adipose tissue. (n = 4). (B) Luciferase assays of adult TA electroporated with linc-MYH
promoter luciferase vectors (indicated) and a TK-Renilla luciferase vector (allowing normalization). *P,0.05. (C) FISH of isolated EDL myofiber with a
linc-MYH antisense RNA fluorescent-labeled probe (green) and Dapi staining (blue).
doi:10.1371/journal.pgen.1004386.g004
linc-MYH Locks Fast Muscle Phenotype
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Figure 5. Slow-type gene expression is suppressed by linc-MYH. (A) qPCR experiments revealing mRNA expression levels of linc-MYH, Six1,
slow-type genes (red) and fast-type genes (blue) in TA muscles expressing a shRNA directed against linc-MYH or LacZ (n = 5). (B) qPCR experiments
revealing pre-mRNA expression of the Tnnt1 and Sln slow genes in TA muscles expressing a shRNA directed against linc-MYH or LacZ (n = 5) (C)
Luciferase activity of pGL3-Enhancer-Myh4 in TA muscles expressing a shRNA directed against linc-MYH or LacZ (n = 4). (D) Microarray analysis of TA
muscles transfected by shRNA against linc-MYH: a heat map of genes (red) upregulated to more than double the levels observed in cSix1KO. (E) qPCR
experiments revealing mRNA expression levels of linc-MYH, Six1, slow-type genes (red) and fast-type genes (blue) in Soleus muscles expressing linc-
Myh or the empty vector pSF (n = 4). (F) qPCR experiments revealing pre-mRNA expression of the Myh4 and Pvalb fast genes in Soleus muscles
expressing linc-Myh or the empty vector pSF (n = 4) (G) A model of Six1 controlling the expression of the differentMYH and of linc-MYH at the fastMyh
locus in fast myofibers. Below, the hypothesis explaining the linc-MYH mode of action, as supported by the transcriptomic-wide analysis performed
after linc-MYH knockdown in fast TA. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pgen.1004386.g005
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MYH expression is not detected. This suggests that their expression
in adult fast myofiber may be restricted by an additional level of
regulation involving the Six1-linc-MYH axis. As a result of our
study we suggest that Six1 controls the acquisition of fast-type
myofiber mechanical properties by binding to a single enhancer
region of the fast Myh locus. It promotes the coordinated
expression of fast Myhs and that of a strong repressor of genes
controlling slow contractile properties. The modulation of Six
activity (depending on fiber-type) facilitates changes in the
expression levels of the fast genes Myh and Tnn; these changes
are required for the formation of efficient sarcomeric units and the
appropriate Ca++ cycling and excitation/contraction/relaxation
coupling [1–4]. The Myh enhancer element therefore connects
distinct regulatory hubs to achieve ultimate muscle fiber special-
ization. In this context, linc-MYH functions as an end-of-the-chain
control element, conveying information on the state of fast Myh
enhancer activity to repress slow-type specific genes and coordi-
nates a finer level of regulation. This genomic organization at the
fast Myh locus is reminiscent of the slow Myh7 locus where two
microRNA miR-208b and miR-499 involved in fast myofiber
program repression are co-regulated with Myh7 [35]. The precise
molecular interactions between linc-Myh and higher order chro-
matin modifying complexes remains to be identified, to explain
how linc-Myh coordinates the activation of target genes at specific
sites in the nucleus, and the repression of others.
Materials and Methods
Mice, ethics statement
Animals were bred and handled as recommended by European
Community guidelines. Experiments were performed in accor-
dance with the guidelines of the French Veterinary Department.
cSix1KO mice were obtained by breeding the Six1-LoxP mice [26]
and transgenic mice expressing a CRE recombinase under the
control of the human skeletal actin promoter (HSA) [25].
ChIP experiments
GP and TA muscles of 2 months old mice were minced with
scissors just after sampling and fixed in 1% formaldehyde for
10 minutes. Formaldehyde was quenched by addition of 0.125 M
glycine, and muscles were washed twice in PBS. The muscles were
incubated on ice in lysis buffer (10 mM Tris-HCl pH 7.9, 85 mM
KCl, 0.5% NP40, protease inhibitors (cOmplete, Roche)) for
10 minutes and homogenized with a mortar and, subsequently
with a Dounce homogenizer. The nuclei were obtained by
centrifugation, incubated in SDS lysis buffer (50 mM Tris-HCl
pH 8, 10 mM EDTA, 1% SDS, protease inhibitors) for 10 min-
utes, and sonicated in a Bioruptor apparatus (Diagenode). The
debris were removed by centrifugation. The sonicated DNA was
incubated with 1 mg of Six1 antibodies (HPA001893, Sigma) under
agitation at +4uC overnight. 20 ml of Dynabeads protein G
(Invitrogen) were added to the samples and incubated under
rotation at +4uC for 1 hour. The beads were washed with low-salt
buffer (2 mM EDTA, 20 mM Tris-HCl pH 8, 150 mM NaCl, 1%
TritonX-100, 0.1% SDS), high salt buffer (2 mM EDTA, 20 mM
Tris-HCl pH 8, 0.5M NaCl, 1% TritonX-100, 0.1% SDS), LiCl
buffer (1 mM EDTA, 10 mM Tris-HCl pH 8, 0.25M LiCl, 1%
NP40, 1% deoxycholate) and TE buffer (1 mM EDTA, 10 mM
Tris-HCl pH 8). The DNA was eluted with elution buffer (1%
SDS, 0.1 M NaHCO3) containing 0.1 mg/ml proteinase K
(Invitrogen) at 62uC for 2 hours, and, proteinase K was inactivated
by incubation at 95uC for 10 minutes. The DNA was finally
purified with MinElute PCR purification kit (Qiagen). The
amount of specific amplified DNA is normalized by beta-Actin
promoter amplification. The sequences of the oligonucleotides
used in this study are as follows. Enh 1F, 59-ATC TCC ACC TCC
CTC CAA CT; Enh 1R, 59-ACC CCC TAG CTT TGA CAG
GT; Enh 2F, 59-AAT CTG ACG ACA GGG TGA GC; Enh 2R,
59-GGT CGC CTG ACC TGA TAG AG; AldoaF, 59-CTC TCA
AGG CAA ACC AAA GC; AldoaR, 59-CCA GTG TCC CAG
ACC TTC TC; ActbF, 59-TGT TAC CAA CTG GGA CGA CA;
ActbR, 59-ACC TGG GTC ATC TTT TCA CG, NCF, 59-ATC
CTG CCC CAC TGT GTT AG; NCR, 59-GCC AGC AAT
TTG GTT TGA AT.
3C experiments
3C experiments were performed as described [36] with few
modifications. Single myofibers were obtained from adult EDL
muscles as previously described [26], cross-linked in 2% formal-
dehyde, 10 mM Tris-HCl pH 7.9, 85 mM KCl, 0.5% NP40 for
10 min at room temperature. Crosslinking reaction was quenched
by 1 M glycine. Cross-linked myofibers were lysed for 10 minutes
with lysis buffer (10 mM Tris-HCl pH 7.9, 85 mM KCl, 0.5%
NP40) on ice, and the nuclei were harvested. Nuclei were
resuspended in appropriate restriction enzyme buffer, 0.3% SDS
and incubated for 1 hour at 37uC with shaking. Triton X-100 was
added to 2%, and samples were incubated for 1 hour at 37uC.
Samples were digested with Hind III overnight at 37uC. DNA
ligation was performed for 4 hours at 16uC and for 30 minutes at
room temperature. Cross-links were reversed, and DNA was then
purified by phenol extraction and ethanol precipitation. To correct
for the PCR amplification efficiency of different primer sets, a
BAC clone containing the mouse Myh locus (RP23-61C14) was
digested, ligated and used as control templates. Quantification of
the data was performed by quantitative real-time PCR using the
Lightcycler 480 probe master (Roche Diagnostic). The sequences
of the oligonucleotides used in this study are given in Table S3.
RNA preparation
TA, back, soleus and GP muscles were collected from cSix1 KO
and control mice. Total RNAs were extracted by Trizol Reagent
(Invitrogen) according to manufacturer’s instruction.
cDNA synthesis and qPCR
RNAs were treated with DNase I (Turbo DNA-free, Invitrogen)
and were reverse transcribed with Superscript III kit (Invitrogen)
according to manufacture’s instruction. Reverse transcription was
performed with 1 mg of total RNA. Quantitative real time PCR
(Light Cycler 480, Roche) was performed using Light Cycler 480
SYBR Green I Master Kit (Roche) according to the manufactur-
er’s protocols. PCR was performed for 40 cycles of 95uC for
15 seconds, 60uC for 15 seconds, and 72uC for 15 seconds. Genes
expression level was normalized by the expression level of the
housekeeping gene Actb. The sequences of the oligonucleotides
used in this study are given in Table S4. Pre-mRNA qPCR
experiments to measure RNA transcription rate were performed in
the same conditions. Reverse oligonucleotides were complemen-
tary to intronic sequences, while forward oligonucleotides were
complementary to exonic sequences. Samples without reverse
transcription were used as controls, and signal due to contam-
inating DNA was subtracted to the values obtained with cDNA.
We noticed that genomic DNA contamination was very low (less
than hundred fold level of qPCR value observed with cDNA).
Muscle contraction test
Skeletal muscle function was evaluated by measuring in situ
muscle contraction, as described previously [37]. 12 week-old male
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mice were anesthetized (intraperitoneal injection of pentobarbital
sodium, 50 mg/kg). Body temperature was maintained at 37uC
using radiant heat. The distal tendon of the TA muscle was
attached to an isometric transducer (Harvard Bioscience) using a
silk ligature. The sciatic nerves were proximally crushed and
distally stimulated by a bipolar silver electrode using supramax-
imal square wave pulses of 0.1 ms duration. Responses to tetanic
stimulation (pulse frequency 50–143 Hz) were successively record-
ed. Maximal forces were determined at optimal length (length at
which maximal force was obtained during the tetanus). Fatigue
resistance was then determined after a 5-minutes rest period. The
muscle was continuously stimulated at 50 Hz for 2 minutes (sub-
maximal continuous tetanus), and the duration corresponding to a
20% decrease in force was recorded.
RNA-FISH
Fluorescent-labeled antisense linc-MYH probes were synthesized
according to manufacturer’s instruction (FISH Tag RNA kit,
Invitrogen). FISH experiments were performed on isolated EDL
myofibres and images acquired on a Leica SP2 confocal
microscope.
Generation of shRNA against mouse linc-MYH
Five distinct shRNAs targeting mouse linc-MYH were designed,
called shlincMYH, and inserted into the psiSTRIKE hMGFP
system (Promega). The efficiency of each shRNA was established
by determination of linc-MYH transcript levels in TA muscles
transfected by each shlincMYH. The shRNA against 59-TTC TGC
TCA CCA CCT ACA ATT-39 sequence was selected for the
knockdown experiment. For knock down experiments using
shlincMYH, a plasmid coding for shLacZ was electroporated in
the contra-lateral TA as a negative control.
Electroporation
In vivo transfections were also carried out on 10-weeks old
C57Bl6 mice. For each experimental conditions, three to five
Tibialis anterior (TA) or Soleus (Sol) muscles belonging to different
mice were used. Under isoflurane anesthesia, legs were shaved and
muscles were pre-treated by injection of a sterile 0.9% NaCl
solution containing 0.4 U of bovine hyaluronidase/ml two hours
before plasmid injection. Ten mg of shRNA-expressing vector were
introduced into TA muscles of 8 week-old mice by electroporation
as previously described [11]. Two weeks following electroporation,
TA myofibers expressing GFP were dissected under a Nikon
SMZ1500 stereo microscope and frozen in liquid nitrogen before
processing for Luciferase assays or RNA purification.
Immunohistochemistry
TA, soleus and gastrocnemius muscles were embedded in
cryomatrix and quickly frozen in isopentane cooled with liquid
nitrogen. Cryostat sections (10 mm) were fixed in 4% PFA, washed
in PBS, permeabilized with 0.1% Triton X-100 and left for 1 hour
in blocking solution (16 PBS, 1.5% goat serum, 0.1% Triton X-
100). Rabbit poly-clonal antibodies directed against Laminin
(Z0097, Dako) (1/100 dilution), and monoclonal antibodies
against MYH7 (NOQ7.5.4D, Sigma) (1/1000 dilution), MYH2
(SC-71, Developmental Studies Hybridoma Bank) (1/20 dilution)
and against MYH4 (BF-F3, Developmental Studies Hybridoma
Bank) (1/20 dilution) were applied overnight at 4uC to the treated
sections. The next day, after three washes with 16PBS containing
0.05% Tween-20, cryosections were incubated for 1 h with
appropriate fluorescent secondary antibodies (Alexa Fluor 488
goat anti-rabbit IgG 1/1000 dilution, Alexa Fluor 594 goat
anti-mouse IgG 1/1000 dilution, Invitrogen). After three washes
with 16PBS containing 0.05% Tween 20, samples were mounted
in Vectashield mounting medium.
Microarray
After validation of RNA quality with the Bioanalyzer 2100
(using Agilent RNA6000 nano chip kit), 50 ng of total RNA were
reverse transcribed following the Ovation PicoSL WTA System
(Nugen). Briefly, the resulting double-strand cDNA was used for
amplification based on SPIA technology. After purification
according to Nugen protocol, 5 mg of single strand DNA was
used for generation of Sens Target DNA using Ovation Exon
Module kit (Nugen). 2.5 mg of Sens Target DNA were fragmented
and labelled with biotin using Encore Biotin Module kit (Nugen).
After control of fragmentation using Bioanalyzer 2100, the cDNA
was then hybridized to GeneChip Mouse Gene 1.0 ST (Affyme-
trix) at 45uC for 17 hours. After overnight hybridization, the
ChIPs were washed using the fluidic station FS450 following
specific protocols (Affymetrix) and scanned using the GCS3000
7G. The scanned images were then analyzed with Expression
Console software (Affymetrix) to obtain raw data (cel files) and
metrics for Quality Controls. The analysis of some of these metrics
and the study of the distribution of raw data show no outlier
experiment. RMA normalization was performed using R and
normalized data was subjected to statistical tests.
EMSA
EMSA was carried out with Six1 full-length mouse cDNA
cloned into the pCR3 vector (Clontech) as previously described
[38]. Recombinant mouse Six1 protein was obtained with a T7
transcription/translation kit (Promega). The oligonucleotide con-
taining double-stranded myogenin MEF3 site was incubated with
recombinant proteins. Competition experiments were performed
in the presence of a ten-fold and hundred-fold molar excess of
unlabeled identified Myh enhancer MEF3 sites (Enh1 to Enh6) or
mutated Myh MEF3 sites (mtEnh1 to mtEnh6), or Myogenin
promoter NFI or MEF3 sites. The sequences of the oligonucle-
otides used are as follows, the MEF3 consensus sequence is
underlined; Enh1F 59-CTC TTG GGT AAC TGG AGC CCC
TC-39. Enh1R 59-GAG GGG CTC CAG TTA CCC AAG AG-
39. Enh2R 59-GGT TGA CTT AGA TTT CCT TAT GA-39.
Enh2F 59-TCA TAA GGA AAT CTA AGT CAA CC-39. Enh3F
59-TGT AAG AGA AAC TGA AAT AAA AT-39. Enh3R 59-
ATT TTA TTT CAG TTT CTC TTA CA-39. Enh4F 59-GGG
GTA AGA AAT CTG ACG ACA GG-39. Enh4R 59-CCT GTC
GTC AGA TTT CTT ACC CC-39. Enh5F 59-CTA TCA GGT
CAG GCG ACC TCA GT-39. Enh5R 59-ACT GAG GTC GCC
TGA CCT GAT AG-39. Enh6F 59-CGT CAA GGA AAC CTT
ATT CCA TC-39. Enh6R 59-GAT GGA ATA AGG TTT CCT
TGA CG-39. MyogF 59-TGG GGG GGC TCA GGT TTC TGT
GGC GT-39. MyogR 59-ACG CCA CAG AAA CCT GAG CCC
CCC CA-39. NF1F 59-TAT CTC TGG GTT CAT GCC AGC
AGG G-39. NF1R 59-CCC TGC TGG CAT GAA CCC AGA
GAT A-39. mtEnh1F 59-CTC TTG GGT AGG ATC CGC CCC
TC-39. mtEnh1R 59-GAG GGG CGG ATC CTA CCC AAG
AG-39. mtEnh2F 59-GGT TGA CGA ATT CTT GCT TAT
GA-39. mtEnh2R 59-TCA TAA GCA AGA ATT CGT CAA CC-
39. mtEnh3F 59-TGT AAG ACC AAC TGA AAT AAA AT-39.
mtEnh3R 59-ATT TTA TTT CAG TTG GTC TTA CA-39.
mtEnh4F 59-GGG GTA AGA AGG ATC CCG ACA GG-39.
mtEnh4R 59-CCT GTC GGG ATC CTT CTT ACC CC-39.
mtEnh5F 59-CTA TCA GGT CGG ATC CCC TCA GT-39.
mtEnh5R 59-ACT GAG GGG ATC CGA CCT GAT AG-39.
linc-MYH Locks Fast Muscle Phenotype
PLOS Genetics | www.plosgenetics.org 9 May 2014 | Volume 10 | Issue 5 | e1004386
mtEnh6F 59-CGT CAA GGA AGG ATC CTT CCA TC-39.
mtEnh6R 59-GAT GGA AGG ATC CTT CCT TGA CG-39.
Western blot
Western blots were performed with protein extracts of GP and
soleus muscles from cSix1KO mice and control mice as previ-
ously described [9]. 1:1000 dilutions of anti-Six1 antibodies
(HPA001893, Sigma) or anti-b2tubulin antibodies (2128, Cell
Signaling) were used.
Statistical analysis
All graphs represent mean values 6 SEM. Significant differ-
ences between mean values were evaluated using two-tailed,
unpaired Student’s t test (when two groups were analyzed) or one-
way ANOVA followed by Student Newman-Keuls test (for three
or more groups).
Plasmids construction
For the construction of the pGL3-Myh2/1/4, c57bl6N mouse
DNA was first used as a template to clone 1.1 kbp promoters of
Myh2/1/4 with forward KpnI/SacI 59-TTC AGA AAC TGC
ATC ACT TAA A-39 and reverse MluI, 59-GCA GCT CGG
GCA GTG GCC AGT GT-39, forward KpnI/SacI 59- CAT
ATC TGC ATC TCT AGA TAC C-39 and reverse MluI, 59-
GGC AGC AGC AGC CAG GAT GTG T-39, forward KpnI/
SacI 59- ACC GCT AGC CTT GAG CCT TTG-39 and reverse
MluI, 59- ATA GCG AGA GCC CTT TGT TCT C-39,
respectively. Myh2/1/4 promoter fragments were subsequently
inserted into an KpnI-MluI digested pGL3 basic plasmid. For the
construction of the pGL3-Enhancer-Myh2/1/4, mouse DNA was
first used as a template to clone the enhancer with forward KpnI
59- GCG TTT CTA ATT CGG CTT GAA C-39 and reverse
SacI, 59- CAT TTC CTT CCT CTA AAG GCT CTT TATT C-
39. This enhancer fragment was subsequently inserted into KpnI-
SacI digested pGL3-Myh2/1/4 plasmids. For the construction of
the pGL3-mutEnhancer-Myh2/1/4, the six MEF3 sites of the
enhancer were mutated as follows; MEF3 1: 59-GTAACTGGA to
59-GTAGGATCC; MEF3 2: 59-TTAGATTTC to 59-GAAT-
TCTTG; MEF3 3: 59-GAAACTGAA to 59-CCAACTGAA;
MEF3 4: 59-GAAATCTGA to 59-GAAGGATCC; MEF3 5: 59-
GTCAGGCGA to 59-GTCGGATCC; MEF3 6: 59-GAAA-
CCTTA to 59-GAAGGATCC. All plasmids sequence was
confirmed by sequencing.
For the construction of the pSF-pA-CMVe-linc-MYH, genomic
DNA fragment containing linc-MYH was obtained from digestion
of a BAC clone containing (RP23-61C14) by BsaWI and AvrII.
The 13.3 kbp DNA fragment was subsequently inserted into a
SpeI-XmaI digested pSF-pA-CMVe plasmid. For linc-Myh gain of
function experiments, the empty pSF-pA-CMVe plasmid was
electroporated in the contra-lateral Soleus as a negative control.
For the construction of the pGL3-Actb, pGL3-Sln and pGL3-Tnni1,
mouse DNA was first used as a template to clone the promoters of
Actb, Sln, and Tnni1 with forward 59- TTT CTC TAT CGA TAG
GTA CCT TTG AGC TCC TGA CCC CGT GTG TAG CTC
T-39 and reverse 59- GAG CCC GGG CTA GCA CGC GTA
AGG AGC TGC AAA GAA GCT G-39, forward 59- TTT CTC
TAT CGA TAG GTA CCT TTG AGC TCT ACC GAC TAT
CAT GCC CAC A-39 and reverse MluI, 59- GAG CCC GGG
CTA GCA CGC GTC AGG CTA CCA AGG ACC TCA G-39,
forward 59- TTT CTC TAT CGA TAG GTA CCT TTG AGC
TCC TGG GAT TTG AAC CCA TGA C-39 and reverse 59-
GAG CCC GGG CTA GCA CGC GTC CTC ACC ACA GAC
TGC AGA G-39, respectively. Actb, Sln, and Tnni1 promoter
fragments were subsequently inserted into a KpnI-MluI site of
pGL3 basic plasmid by GeneArt kit (Life Technologies). For the
construction of the pGL3-Enhancer-Actb, pGL3-Enhancer-Sln and
pGL3-Enhancer-Tnni1, the enhancer fragment was subsequently
inserted into an KpnI-SacI site of pGL3-Actb, pGL3-Sln and
pGL3-Tnni1plasmids. All plasmids sequence were confirmed by
sequencing.
Luciferase assays
Two mg of Luciferase-expressing vector and one hundred ng of
pRL-TK vector (Promega) were introduced into TA muscles of 8
week-old mice by electroporation as previously described [11].
Two weeks following electroporation, the TA muscles were
dissected and frozen in liquid nitrogen before processing. The
TA muscles were homogenized in Passive Lysis Buffer (Dual-
Luciferase Reporter Assay System, Promega) and rotated for
15 minutes. The homogenate were centrifuged to remove debris,
and the supernatant was used for measurement of Luciferase
activity according to manufacture’s instruction (Dual-Luciferase
Reporter Assay System, Promega).
Computational analysis
In order to computationally identify MEF3 binding sites, we
built a PWM (position-specific weight matrix) for MEF3, starting
from a list of 15 binding sites (see Table S5) that were previously
tested by Electrophoretic Mobility Shift Assay on the basis of their
proximity to the MEF3 Myogenin consensus GAAACCTGA [10].
The PWM (shown in Figure S6 and Table S6) was generated by
running the de novo motif finder Imogene [39] on small DNA
fragments (see Table S5) that contained these binding sites.
Imogene used phylogeny to enrich mouse set of DNA fragments
with orthologs in 11 other mammalian sequenced genomes and to
produce a refined PWM. The information content of the PWM
(the genmot Sg parameter of Imogene) was set to 8.7 bits. Binding
sites were predicted using a prediction threshold (the scangen Ss
parameter of Imogene) of 9 bits and requiring conservation, as
explained in [39].
Supporting Information
Figure S1 Sequences of P1 and P2 boxes of the Myh enhancer.
Sequences of P1 and P2 boxes of the Myh enhancer in mouse, rat,
human, bovine and equinides species, and showing the sequence
conservation of the six MEF3 sites and E boxes. Coordinates are in
mm9 assembly.
(TIF)
Figure S2 Predicted linc-MYH structure. Predicted minimum
free energy (MFE) structure of the 1050 nt long linc-MYH, as
determined by RNAfold [40]. The color encodes base-pair
probabilities.
(TIF)
Figure S3 (A). Competitive Electromobility shift assays. Com-
petitive Electromobility shift assays performed with recombinant
Six1 proteins and labeled Myogenin MEF3 oligonucleotide and 10
or 100 fold molar excess of unlabelled oligonucleotides containing
Myogenin MEF3 or NF1 site, with MYH MEF3 sites (1, 2, 3, 4, 5,
6) or with mutated MYH MEF3 sites whose sequence is presented
on Figure S1 and in the Materials and Methods section. (B). qPCR
experiments measuring the relative levels of Sln mRNA in adult wt
TA and Sol. (C). Luciferase assays of adult TA transfected with Sln,
Tnni1 and Actb promoters with or without the Myh enhancer. TA
sampling was performed two weeks after the electroporation,
(n = 4). (D). Primary embryonic fibroblasts were transfected with
Luciferase plasmids under the control of Myh4 promoter or Myh4
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promoter linked with the Myh enhancer. After transfection,
fibroblasts were cultured two days before sampling, (n = 3). *P,
0.05, ***P,0.001.
(TIF)
Figure S4 Immunostaining of MYH proteins. Immunostaining
of MYH7 (red), MYH2 (red), MYH4 (red) and laminin (green) in
TA of 12 weeks old control and cSix1KO male mice.
(TIF)
Figure S5 Comparison between cSix1 mice and shlinc-MYH
treated mice. (A) Venn diagram showing the overlap between
genes that are up-regulated more than five fold in shlinc-MYH and
two fold in cSix1 muscles. (p = 10217 as given by a hypergeometric
test). (B) Scatter plot of mRNA expression fold change (log2) as
determined by microarray analysis of shlinc-MYH and cSix1. Genes
that are up-regulated more than five fold in shlinc-MYH and two
fold in cSix1 muscles are indicated in red. (C) mRNA expression
levels in shlinc-MYH knock-down and cSix1 TA muscles, as
measured by qPCR experiments. Ctrl (means 6 SEM; n=4),
cSix1 (means 6 SEM; n= 4), shLacZ (means 6 SEM; n=5), shlinc-
MYH (means 6 SEM; n= 5). (D) mRNA expression level of
Ankrd1, Zdbf2 and Peg10 in back muscles of cSix1 KO mice at
E18.5, P2W, P4W and P8W, as determined by qPCR experi-
ments, (means 6 SEM; n= 3 to 6 for each point). *P,0.05, **P,
0.01, ***P,0.001.
(TIF)
Figure S6 MEF3 PWM used in this study.
(TIF)
Table S1 Microarrays analysis of TA muscles electroporated by
shRNA.
(XLS)
Table S2 Microarrays analysis of GP muscles of cSix1.
(XLS)
Table S3 Sequence of the oligonucleotides used for 3C.
(DOCX)
Table S4 Sequence of the oligonucleotides used for qPCR.
(DOCX)
Table S5 Coordinates (mm9) of the fragments used to learn the
MEF3 PWM.
(DOCX)
Table S6 MEF3 frequency matrix.
(DOCX)
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